THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,950,912 | -19.5% | 689,561 | -3.4% | 0.01% | -25.0% |
| Q2 2023 | $7,391,080 | -32.9% | 714,114 | -29.6% | 0.01% | -33.3% |
| Q1 2023 | $11,012,675 | -37.6% | 1,014,993 | -35.5% | 0.01% | -40.0% |
| Q4 2022 | $17,645,133 | +9.6% | 1,572,650 | -0.9% | 0.02% | +5.3% |
| Q3 2022 | $16,094,000 | +28.7% | 1,587,198 | +15.0% | 0.02% | +26.7% |
| Q2 2022 | $12,507,000 | +5.6% | 1,380,397 | +11.4% | 0.02% | +36.4% |
| Q1 2022 | $11,845,000 | +22.3% | 1,239,042 | +41.4% | 0.01% | +37.5% |
| Q4 2021 | $9,684,000 | +211.6% | 876,463 | +108.7% | 0.01% | +166.7% |
| Q3 2021 | $3,108,000 | +171.9% | 420,051 | +649.9% | 0.00% | +200.0% |
| Q1 2021 | $1,143,000 | +83.5% | 56,014 | +59.8% | 0.00% | 0.0% |
| Q4 2020 | $623,000 | -39.0% | 35,060 | -49.2% | 0.00% | 0.0% |
| Q3 2020 | $1,021,000 | -35.2% | 69,031 | -8.0% | 0.00% | -50.0% |
| Q2 2020 | $1,575,000 | +39.3% | 75,024 | +53.3% | 0.00% | +100.0% |
| Q1 2020 | $1,131,000 | +9.2% | 48,951 | +22.4% | 0.00% | 0.0% |
| Q4 2019 | $1,036,000 | +31.3% | 40,000 | -1.2% | 0.00% | 0.0% |
| Q3 2019 | $789,000 | -18.2% | 40,500 | -31.4% | 0.00% | 0.0% |
| Q2 2019 | $964,000 | +21.9% | 59,039 | +69.3% | 0.00% | 0.0% |
| Q1 2019 | $791,000 | -58.8% | 34,871 | -53.5% | 0.00% | -66.7% |
| Q4 2018 | $1,920,000 | +14.9% | 75,034 | +46.7% | 0.00% | +50.0% |
| Q3 2018 | $1,671,000 | +103.5% | 51,149 | +41.4% | 0.00% | +100.0% |
| Q2 2018 | $821,000 | -53.5% | 36,178 | -50.4% | 0.00% | -50.0% |
| Q1 2018 | $1,767,000 | -27.7% | 72,869 | -16.8% | 0.00% | -33.3% |
| Q4 2017 | $2,443,000 | -21.5% | 87,584 | -3.6% | 0.00% | -40.0% |
| Q3 2017 | $3,111,000 | -56.3% | 90,848 | -49.2% | 0.01% | -58.3% |
| Q2 2017 | $7,120,000 | +81.8% | 178,707 | +68.0% | 0.01% | +71.4% |
| Q1 2017 | $3,917,000 | +2.0% | 106,392 | -11.7% | 0.01% | 0.0% |
| Q4 2016 | $3,840,000 | +33.6% | 120,437 | +51.9% | 0.01% | +40.0% |
| Q3 2016 | $2,874,000 | +121.9% | 79,305 | +38.9% | 0.01% | +150.0% |
| Q2 2016 | $1,295,000 | -76.1% | 57,079 | -80.2% | 0.00% | -80.0% |
| Q1 2016 | $5,415,000 | -19.4% | 288,070 | -29.8% | 0.01% | 0.0% |
| Q4 2015 | $6,722,000 | +49.0% | 410,127 | -0.1% | 0.01% | +42.9% |
| Q3 2015 | $4,510,000 | -23.2% | 410,407 | -9.0% | 0.01% | -22.2% |
| Q2 2015 | $5,869,000 | -23.8% | 450,776 | +1.5% | 0.01% | -25.0% |
| Q1 2015 | $7,704,000 | -21.5% | 444,031 | -32.5% | 0.01% | 0.0% |
| Q4 2014 | $9,809,000 | -39.7% | 657,439 | -6.9% | 0.01% | -45.5% |
| Q3 2014 | $16,276,000 | +16.0% | 706,134 | +60.4% | 0.02% | +15.8% |
| Q2 2014 | $14,033,000 | – | 440,192 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |